BATON ROUGE, La., Jan. 30, 2017 -- Amedisys, Inc. (NASDAQ:AMED), a leading home health, hospice and personal care company, announced today that David Mikula will join the Company as Chief Development Officer, effective January 30, 2017.
Mikula has held key leadership roles across the healthcare spectrum in operations, sales and marketing, with experience ranging from occupational health and rehab services to hospitals and post-acute care. Most recently, he served as Senior Vice President and Chief Operating Officer for the Texas Region of Kindred Healthcare’s hospital division, where he was responsible for planning and directing the operational policies, objectives and initiatives for 20 sites of service with $651M in budgeted revenue.
Previously, Mikula was the Senior Vice President of Sales and Marketing for Kindred’s hospital and skilled nursing divisions, and was then promoted to Senior Vice President of Sales and Marketing for Kindred Healthcare. He was responsible for the design, drive and development of all enterprise sales activities for Kindred. His career began at Concentra, a $1 billion provider of occupational health and urgent care services.
“David is an impressive and results-oriented executive,” said President and CEO Paul Kusserow. “His depth of expertise in developing and implementing successful growth strategies and running sales and marketing teams will make him a valued addition to our leadership team.”
“This is an exciting opportunity for me,” said David. “I feel privileged to join an organization whose number-one strategy is to become the best choice for care wherever our patients call home.”
In his new position at Amedisys, Mikula will research the market to identify new opportunities for organic growth; devise a sales/business development strategy designed to achieve the Company’s revenue goals; and enhance market presence in the home health industry.
About Amedisys
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,200 hospitals and 61,900 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With more than 16,000 employees, in 427 care centers in 34 states, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 340,000 patients in need every year. For more information about the Company, please visit: www.amedisys.com.
Contact: Kendra Kimmons Managing Director of Communications 225-299-3708 [email protected]


Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Britain Courts Anthropic Amid US Defense Department Dispute
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 



